After reconstitution, the solution should be clear and colourless
A vendors use of GLP-3 peptide does not create a legitimate approved category or make an experimental product equivalent to the material used in a clinical trial
van der Valk ME, Mangen M-JJ, Severs M, van der Have M, Dijkstra G, van Bodegraven AA, Fidder HH, de Jong DJ, van der Woude CJ, Romberg-Camps MJL, Clemens CHM, Jansen JM, van de Meeberg PC, Mahmmod N, van der Meulen-de Jong AE, Ponsioen CY, Bolwerk C, Vermeijden JR, Siersema PD, Leenders M, Oldenburg B, COIN study group and the Dutch Initiative on Crohn and Colitis (2016) Evolution of costs of inflammatory bowel disease over two years of follow-up
Dakanalis Antonios M, Maria P, Souzana K, et al